Literature DB >> 17959756

Molecular epidemiology of Escherichia coli producing extended-spectrum beta-lactamases isolated in Rome, Italy.

Alessandra Carattoli1, Aurora García-Fernández, Paola Varesi, Daniela Fortini, Serena Gerardi, Adriano Penni, Carlo Mancini, Alessandra Giordano.   

Abstract

Escherichia coli strains producing extended-spectrum beta-lactamases (ESBLs) are a major problem in many different hospitals worldwide, causing outbreaks as well as sporadic infections. The prevalence of Escherichia coli ESBL producers was analyzed in a surveillance study performed on the population attending the Policlinico Umberto I, the largest university hospital in Rome, Italy. We also investigated genotypes, pathogenicity islands, and plasmids in the ESBL-positive E. coli isolates as further markers that are useful in describing the epidemiology of the infections. In this survey, 163 nonreplicate isolates of Escherichia coli were isolated from patients from 86 different wards, and 28 were confirmed as ESBL producers. A high prevalence (26/28) of CTX-M-15 producers was observed within the bacterial population circulating in this hospital, and the dissemination of this genetic trait was associated with the spread of related strains; however, these do not have the characteristics of a single epidemic clone spreading. The dissemination was also linked to horizontal transfer among the prevalent E. coli genotypes of multireplicon plasmids showing FIA, FIB, and FII replicons in various combinations, which are well adapted to the E. coli species. The analysis of related bacteria suggests a probable interpatient transmission occurring in several wards, causing small outbreaks.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17959756      PMCID: PMC2224243          DOI: 10.1128/JCM.01542-07

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  32 in total

1.  Molecular characterization of extended-spectrum beta-lactamases produced by nosocomial isolates of Enterobacteriaceae from an Italian nationwide survey.

Authors:  Mariagrazia Perilli; Emanuela Dell'Amico; Bernardetta Segatore; Maria Rosaria de Massis; Ciro Bianchi; Francesco Luzzaro; Gian Maria Rossolini; Antonio Toniolo; Giuseppe Nicoletti; Gianfranco Amicosante
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

2.  Rapid and simple determination of the Escherichia coli phylogenetic group.

Authors:  O Clermont; S Bonacorsi; E Bingen
Journal:  Appl Environ Microbiol       Date:  2000-10       Impact factor: 4.792

Review 3.  Escherichia coli in disguise: molecular origins of Shigella.

Authors:  Ruiting Lan; Peter R Reeves
Journal:  Microbes Infect       Date:  2002-09       Impact factor: 2.700

Review 4.  CTX-M: changing the face of ESBLs in Europe.

Authors:  David M Livermore; Rafael Canton; Marek Gniadkowski; Patrice Nordmann; Gian Maria Rossolini; Guillaume Arlet; Juan Ayala; Teresa M Coque; Izabela Kern-Zdanowicz; Francesco Luzzaro; Laurent Poirel; Neil Woodford
Journal:  J Antimicrob Chemother       Date:  2006-12-06       Impact factor: 5.790

5.  CTX-M beta-lactamase-producing Escherichia coli in French hospitals: prevalence, molecular epidemiology, and risk factors.

Authors:  Jean-Philippe Lavigne; Hélène Marchandin; Julien Delmas; Jérôme Moreau; Nicole Bouziges; Evelyne Lecaillon; Laurent Cavalie; Hélène Jean-Pierre; Richard Bonnet; Albert Sotto
Journal:  J Clin Microbiol       Date:  2006-11-15       Impact factor: 5.948

6.  Occurrence of extended spectrum beta-lactamases among isolates of Enterobacteriaceae from urinary tract infections in southern Italy.

Authors:  Marisa Caccamo; Mariagrazia Perilli; Giuseppe Celenza; Giovanni Bonfiglio; Gianna Tempera; Gianfranco Amicosante
Journal:  Microb Drug Resist       Date:  2006       Impact factor: 3.431

7.  Development of a sensitive and specific enzyme-linked immunosorbent assay for detecting and quantifying CMY-2 and SHV beta-lactamases.

Authors:  Andrea M Hujer; Malcolm G P Page; Marion S Helfand; Bethany Yeiser; Robert A Bonomo
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

8.  Standardization of pulsed-field gel electrophoresis protocols for the subtyping of Escherichia coli O157:H7, Salmonella, and Shigella for PulseNet.

Authors:  Efrain M Ribot; M A Fair; R Gautom; D N Cameron; S B Hunter; B Swaminathan; Timothy J Barrett
Journal:  Foodborne Pathog Dis       Date:  2006       Impact factor: 3.171

9.  Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes.

Authors:  E Lautenbach; J B Patel; W B Bilker; P H Edelstein; N O Fishman
Journal:  Clin Infect Dis       Date:  2001-03-26       Impact factor: 9.079

10.  Evidence for convergent evolution of CTX-M-14 ESBL in Escherichia coli and its prevalence.

Authors:  Ferran Navarro; Rául-Jesús Mesa; Elisenda Miró; Laura Gómez; Beatriz Mirelis; Pere Coll
Journal:  FEMS Microbiol Lett       Date:  2007-06-07       Impact factor: 2.742

View more
  30 in total

1.  Prevalence of TEM, SHV, and CTX-M genes of extended-spectrum β-lactamase-producing Escherichia coli strains isolated from urinary tract infections in adults.

Authors:  Jayanti Jena; Rajesh Kumar Sahoo; Nagen Kumar Debata; Enketeswara Subudhi
Journal:  3 Biotech       Date:  2017-07-14       Impact factor: 2.406

Review 2.  Resistance plasmid families in Enterobacteriaceae.

Authors:  Alessandra Carattoli
Journal:  Antimicrob Agents Chemother       Date:  2009-03-23       Impact factor: 5.191

3.  Fatal sepsis by Klebsiella pneumoniae in a patient with systemic lupus erythematosus: the importance of postmortem microbiological examination for the ex post diagnosis of infection.

Authors:  Cristian D'Ovidio; Arianna Pompilio; Valentina Crocetta; Giovanni Gherardi; Aldo Carnevale; Giovanni Di Bonaventura
Journal:  Int J Legal Med       Date:  2015-02-13       Impact factor: 2.686

4.  Extended-spectrum-β-lactamase-producing Escherichia coli isolate possessing the Shiga toxin gene (stx1) belonging to the O64 serogroup associated with human disease in India.

Authors:  T K Dutta; Iadarilin Warjri; P Roychoudhury; H Lalzampuia; I Samanta; S N Joardar; S Bandyopadhyay; Rajesh Chandra
Journal:  J Clin Microbiol       Date:  2013-04-10       Impact factor: 5.948

5.  Plasmid-mediated fluoroquinolone resistance determinants in Escherichia coli from community uncomplicated urinary tract infection in an area of high prevalence of quinolone resistance.

Authors:  C Longhi; M P Conte; M Marazzato; V Iebba; V Totino; F Santangelo; C Gallinelli; L Pallecchi; E Riccobono; S Schippa; A Comanducci
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-12-31       Impact factor: 3.267

Review 6.  Trends in human fecal carriage of extended-spectrum β-lactamases in the community: toward the globalization of CTX-M.

Authors:  Paul-Louis Woerther; Charles Burdet; Elisabeth Chachaty; Antoine Andremont
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

7.  Phenotypic and molecular characterization of two novel CTX-M enzymes carried by Klebsiella pneumoniae.

Authors:  Jun Cheng; Wei Gao; Jun Yin; Zhen Sun; Ying Ye; Yu-Feng Gao; Xu Li; Jia-Bin Li
Journal:  Mol Biol Rep       Date:  2009-03-18       Impact factor: 2.316

8.  International clones of Klebsiella pneumoniae and Escherichia coli with extended-spectrum beta-lactamases in a Czech hospital.

Authors:  Jaroslav Hrabák; Joanna Empel; Tamara Bergerová; Karel Fajfrlík; Pavla Urbásková; Izabela Kern-Zdanowicz; Waleria Hryniewicz; Marek Gniadkowski
Journal:  J Clin Microbiol       Date:  2009-08-26       Impact factor: 5.948

9.  Efficacy of current guidelines for the treatment of spontaneous bacterial peritonitis in the clinical practice.

Authors:  Stefania Angeloni; Cinzia Leboffe; Antonella Parente; Mario Venditti; Alessandra Giordano; Manuela Merli; Oliviero Riggio
Journal:  World J Gastroenterol       Date:  2008-05-07       Impact factor: 5.742

10.  Conjugative IncFI plasmids carrying CTX-M-15 among Escherichia coli ESBL producing isolates at a University hospital in Germany.

Authors:  Stephen E Mshana; Can Imirzalioglu; Hamid Hossain; Torsten Hain; Eugen Domann; Trinad Chakraborty
Journal:  BMC Infect Dis       Date:  2009-06-17       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.